| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |